posted on 2018-05-24, 00:00authored bySoham Samanta, Senjuti Halder, Gopal Das
Two cyanine-based fluorescent probes,
(E)-2-(4-(diethylamino)-2-hydroxystyryl)-3-ethyl-1,1-dimethyl-1H-benzo[e]indol-3-ium iodide (L) and (E)-3-ethyl-1,1-dimethyl-2-(4-nitrostyryl)-1H-benzo[e]indol-3-ium iodide (L1), have been designed and synthesized. Of
these two probes, the twisted-intramolecular-charge-transfer (TICT)-based
probe, L, can preferentially self-assemble to form nanoaggregates. L displayed a selective turn-on fluorescence response toward
human and bovine serum albumin (HSA and BSA) in ∼100% aqueous
PBS medium, which is noticeable with the naked eye, whereas L1 failed to sense these albumin proteins.
The selective turn-on fluorescence response of L toward
HSA and BSA can be attributed to the selective binding of probe L with HSA and BSA without its interfering with known drug-binding
sites. The specific binding of L with HSA led to the
disassembly of the self-assembled nanoaggregates of L, which was corroborated by dynamic-light-scattering (DLS) and transmission-electron-microscopy
(TEM) analysis. Probe L has a limit of detection as low
as ∼6.5 nM. The sensing aptitude of probe L to
detect HSA in body fluid and an artificial-urine sample has been demonstrated.